A Network Inference Method for Large-Scale Unsupervised Identification of Novel Drug-Drug Interactions

GuimerĂ , Roger; Sales-Pardo, Marta
December 2013
PLoS Computational Biology;Dec2013, Vol. 9 Issue 12, p1
Academic Journal
Characterizing interactions between drugs is important to avoid potentially harmful combinations, to reduce off-target effects of treatments and to fight antibiotic resistant pathogens, among others. Here we present a network inference algorithm to predict uncharacterized drug-drug interactions. Our algorithm takes, as its only input, sets of previously reported interactions, and does not require any pharmacological or biochemical information about the drugs, their targets or their mechanisms of action. Because the models we use are abstract, our approach can deal with adverse interactions, synergistic/antagonistic/suppressing interactions, or any other type of drug interaction. We show that our method is able to accurately predict interactions, both in exhaustive pairwise interaction data between small sets of drugs, and in large-scale databases. We also demonstrate that our algorithm can be used efficiently to discover interactions of new drugs as part of the drug discovery process.


Related Articles

  • Combined Systems Approaches Reveal Highly Plastic Responses to Antimicrobial Peptide Challenge in Escherichia coli. Kozlowska, Justyna; Vermeer, Louic S.; Rogers, Geraint B.; Rehnnuma, Nabila; Amos, Sarah-Beth T. A.; Koller, Garrit; McArthur, Michael; Bruce, Kenneth D.; Mason, A. James // PLoS Pathogens;May2014, Vol. 10 Issue 5, p1 

    Obtaining an in-depth understanding of the arms races between peptides comprising the innate immune response and bacterial pathogens is of fundamental interest and will inform the development of new antibacterial therapeutics. We investigated whether a whole organism view of antimicrobial...

  • The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation. Seong-Cheol Park; Yoonkyung Park; Kyung-Soo Hahm // International Journal of Molecular Sciences;Sep2011, Vol. 12 Issue 9, p5971 

    Over the last decade, decreasing effectiveness of conventional antimicrobial-drugs has caused serious problems due to the rapid emergence of multidrug-resistant pathogens. Furthermore, biofilms, which are microbial communities that cause serious chronic infections and dental plaque, form...

  • Drug interactions with antidepressants. Hanson, Philip D. // Psychotherapy Letter;May95, Vol. 7 Issue 5, following p8 

    Presents a chart and discussion on the interactions between selected drugs and antidepressants. Includes interaction of Bupropion with Clondine and other drugs; Fluoxetine with Alprazolam; Fluvoxamine with barbiturates; Paroxitine with Carbamazepine; Paroxetine with lithium; Sertraline with...

  • SAR by HCS. Lang, Paul // Nature Chemical Biology;Jan2008, Vol. 4 Issue 1, p18 

    The article presents a study on the use of high-content screening (HCS) data in predicting the mechanism of action of small-molecule hits. The HSC data was derived through an integration of an HCS analysis with complementary computational tools. The study indicates that HCS is an important tool...

  • Rating Risk. Wyenandt, Andy; McGrath, Meg T. // American Vegetable Grower;May2007, Vol. 55 Issue 5, p24 

    The article focuses on the significant role of fungicides with multi-site mode of action (MOA) in fungicide resistance development. It discusses the benefits associated with having a high risk for resistance development including the specificity of MOAs which helps reduce overall impacts to...

  • Quinolones: A Therapeutic Review. Malik, Sachin; Choudhary, Ashish; Kumar, Sachin; Avasthi, Garima // Journal of Pharmacy Research;Jul2010, Vol. 3 Issue 7, p1519 

    This therapeutic review discusses the Chemistry, Mechanism of Action, Resistance, Pharmacokinetics, Syntheses; Spectrum of activity, Clinical application, drug interactions. Particular emphasis is placed on clinical application of quinolones. The quinolones antibiotics are synthetic derivatives...

  • Microbial Drug Efflux Proteins of the Major Facilitator Superfamily. Saidijam, Massoud; Benedetti, Giulia; Qinghu Ren; Zhiqiang Xu; Hoyle, Christopher J.; Palmer, Sarah L.; Ward, Alison; Bettaney, Kim E.; Szakonyi, Gerda; Meuller, Johan; Morrison, Scott; Pos, Martin K.; Butaye, Patrick; Walraven, Karl; Langton, Kate; Herbert, Richard B.; Skurray, Ronald A.; Paulsen, Ian T.; O'Reilly, John; Rutherford, Nicholas G. // Current Drug Targets;Jul2006, Vol. 7 Issue 7, p793 

    Drug efflux proteins are widespread amongst microorganisms, including pathogens. They can contribute to both natural insensitivity to antibiotics and to emerging antibiotic resistance and so are potential targets for the development of new antibacterial drugs. The design of such drugs would be...

  • Antibiotics Final Common Pathway. Breindl, Anette // BioWorld Today;4/23/2012, Vol. 23 Issue 78, Special section p2 

    The article discusses research on how antibiotics kill bacteria through a common molecular mechanism, published in the April 20, 2012 issue of "Science."

  • Antidepressant alert.  // HealthFacts;Apr95, Vol. 20 Issue 191, p2 

    Reports on the warning issued by the Food and Drug Administration (FDA) about the serious and sometimes fatal interactions of Eldepryl, a drug used to treat Parkinson's disease, with types of antidepressant drugs known as MAO inhibitors. Adverse interactions between Eldepryl and antidepressants...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics